000 01622 a2200457 4500
005 20250512005726.0
264 0 _c19890817
008 198908s 0 0 eng d
022 _a0009-9236
024 7 _a10.1038/clpt.1989.103
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKallio, A
245 0 0 _aEffects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cJul 1989
300 _a33-42 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic alpha-Agonists
_xpharmacology
650 0 4 _aAdult
650 0 4 _aArginine Vasopressin
_xblood
650 0 4 _aAtrial Natriuretic Factor
_xblood
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xblood
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aMale
650 0 4 _aMedetomidine
650 0 4 _aNorepinephrine
_xblood
650 0 4 _aReceptors, Adrenergic, alpha
_xdrug effects
650 0 4 _aRenin
_xblood
650 0 4 _aStereoisomerism
700 1 _aScheinin, M
700 1 _aKoulu, M
700 1 _aPonkilainen, R
700 1 _aRuskoaho, H
700 1 _aViinamäki, O
700 1 _aScheinin, H
773 0 _tClinical pharmacology and therapeutics
_gvol. 46
_gno. 1
_gp. 33-42
856 4 0 _uhttps://doi.org/10.1038/clpt.1989.103
_zAvailable from publisher's website
999 _c2574155
_d2574155